Primary and precise diagnosis of malaria is essential for both fast and effective disease management and observation. Superior quality malaria diagnosis systems are important in all settings as misdiagnosis or misinterpretation can result in substantial morbidity and mortality. World Health Organization (WHO) recommends a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected malaria before treatment is being administered. Diagnostic testing improves the overall management of patients with febrile illnesses and may also help to decrease the emergence and spread of drug resistance by storing antimalarials for those who have the disease. The scope of malaria diagnostics is growing rapidly with technological advancements and a growing number of investments. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the malaria diagnostics market.The malaria diagnostics market is expected to grow at 4.6% CAGR during the forecast period
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6432
However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is also a prime concern for the manufacturers and healthcare providers.
The global malaria diagnostics market has been segmented on the basis of technology and end-user.
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR). On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
The Americas is projected to lead the malaria diagnostics market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.
The European market is expected to hold the second largest market share. The European market is projected to grow because of the malaria cases brought in the European region by tourists and refugees. The European Centre for Disease Prevention and Control, stats reported a range of 5000 -7000 cases of malaria from 2008 to 2012.
Asia-Pacific is projected to be the fastest growing region for the global malaria diagnostics market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. The diagnostic testing market, by volume, in India is controlled by microscopy testing. With increasing awareness and growing funding from care-based surveillance systems, private sectors and national governments the necessity for diagnostic testing procedures are projected to rise, thereby boosting the market development.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. Southeast Asia accounted for about 10% of the global cases, however, the death rate was around 7% in the same year.
Some of the key players in the global malaria diagnostics market are
Access Bio. Inc.,
Premier Medical Corporation Pvt. Ltd,
Sysmex Partec GmbH,
bioMérieux, Beckman Coulter Inc.,
Leica Microsystems GmbH,
and Bio-Rad Laboratories Inc.
Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Malaria Diagnostics Market, By Technique
Chapter 7. Global Malaria Diagnostics Market, By End-Users
Chapter 8. Global Hemostats Market, By Region
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Get in touch: